PURPOSE: The purpose of this paper is to consider the potential benefits and challenges of applying a strategy of "seek, test, treat and retain" (STTR) to hepatitis C virus (HCV) in the US criminal justice system. DESIGN/METHODOLOGY/APPROACH: The authors draw on the published literature to illustrate how each component of STTR could be applied to HCV in the US criminal justice system, and describe challenges to the implementation of this strategy. FINDINGS: The burden of morbidity and mortality associated with chronic HCV infection in the USA is increasing and without significantly increased treatment uptake, will likely continue to do so for several decades. The authors argue that the US criminal justice system is an ideal focus for HCV case finding and treatment due to a high prevalence of infection and large volume of individuals in contact with this system. STTR would identify large numbers of HCV infections, leading to opportunities for secondary prevention and primary care. Important challenges to the implementation of STTR include treatment costs and training of prison medical providers. ORIGINALITY/VALUE: This paper highlights opportunities to address HCV in the US criminal justice system.
PURPOSE: The purpose of this paper is to consider the potential benefits and challenges of applying a strategy of "seek, test, treat and retain" (STTR) to hepatitis C virus (HCV) in the US criminal justice system. DESIGN/METHODOLOGY/APPROACH: The authors draw on the published literature to illustrate how each component of STTR could be applied to HCV in the US criminal justice system, and describe challenges to the implementation of this strategy. FINDINGS: The burden of morbidity and mortality associated with chronic HCV infection in the USA is increasing and without significantly increased treatment uptake, will likely continue to do so for several decades. The authors argue that the US criminal justice system is an ideal focus for HCV case finding and treatment due to a high prevalence of infection and large volume of individuals in contact with this system. STTR would identify large numbers of HCV infections, leading to opportunities for secondary prevention and primary care. Important challenges to the implementation of STTR include treatment costs and training of prison medical providers. ORIGINALITY/VALUE: This paper highlights opportunities to address HCV in the US criminal justice system.
Authors: Jacques Baillargeon; Roger D Soloway; David Paar; Thomas P Giordano; Owen Murray; James Grady; Brie Williams; John Pulvino; Ben G Raimer Journal: Ann Epidemiol Date: 2007-08-06 Impact factor: 3.797
Authors: Jacques Baillargeon; Thomas P Giordano; Josiah D Rich; Z Helen Wu; Katherine Wells; Brad H Pollock; David P Paar Journal: JAMA Date: 2009-02-25 Impact factor: 56.272
Authors: Judith I Tsui; Claire M Miller; John D Scott; Maria A Corcorran; Julia C Dombrowski; Sara N Glick Journal: Drug Alcohol Depend Date: 2018-12-26 Impact factor: 4.492
Authors: Curt G Beckwith; Ann E Kurth; Lauri B Bazerman; Emily J Patry; Alice Cates; Liem Tran; Amanda Noska; Irene Kuo Journal: J Public Health (Oxf) Date: 2015-03-02 Impact factor: 2.341
Authors: Josiah D Rich; Curt G Beckwith; Alexandria Macmadu; Brandon D L Marshall; Lauren Brinkley-Rubinstein; Joseph J Amon; M-J Milloy; Maximilian R F King; Jorge Sanchez; Lukoye Atwoli; Frederick L Altice Journal: Lancet Date: 2016-07-14 Impact factor: 79.321
Authors: Des Crowley; Gordana Avramovic; Walter Cullen; Collette Farrell; Anne Halpin; Mary Keevans; Eamon Laird; Tina McHugh; Susan McKiernan; Sarah Jayne Miggin; Ross Murtagh; Eileen O Connor; Marie O'Meara; Deirdre O Reilly; John S Lambert Journal: Arch Public Health Date: 2021-06-08
Authors: Desmond Crowley; Ross Murtagh; Walter Cullen; Mary Keevans; Eamon Laird; Tina McHugh; Susan McKiernan; Sarah Jayne Miggin; Eileen O'Connor; Deirdre O'Reilly; Graham Betts-Symonds; Ciara Tobin; Marie Claire Van Hout; John S Lambert Journal: Harm Reduct J Date: 2019-07-05
Authors: Dana Busschots; Cécile Kremer; Rob Bielen; Özgür M Koc; Leen Heyens; Christian Brixko; Pierre Laukens; Hans Orlent; Pascal Bilaey; Francis De Smet; Geert Hellemans; Gaetan Muyldermans; Luk Van Baelen; Niel Hens; Hans Van Vlierberghe; Geert Robaeys Journal: BMC Infect Dis Date: 2021-07-27 Impact factor: 3.090